Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $150.0000 (3.45%) ($145.0000 - $160.0000) on Wed. Apr. 18, 2012. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.2% (three month average) | RSI | 21 | Latest Price | $150.0000(3.45%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | CAPR declines -16.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) IWM(4%) EWP(3%) XAR(3%) XOP(3%) | Factors Impacting CAPR price | CAPR will decline at least -3.1% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) EWY(-1%) XLU(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.1% (StdDev 6.2%) | Hourly BBV | 0 () | Intraday Trend | 3.4% | | | |
|
1 - 5 Day Possible Target | $119.65(-20.23%) | Resistance Level | $194.55 | 5 Day Moving Average | $151.6(-1.06%) | 10 Day Moving Average | $154.3(-2.79%) | 20 Day Moving Average | $194.55(-22.9%) | To recent high | -48.3% | To recent low | 3.4% | Market Cap | $2.955b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |